Gambia vs Liberia: Cause of death, by non-communicable diseases, ages 5-14
Gambia
22.0%
in 2021
Liberia
21.7%
in 2021
Gambia rank
150th
Liberia rank
151st
Cause of death, by non-communicable diseases, ages 5-14 over time
- Gambia
- Liberia
How they compare
Gambia currently reports 22.0% against 21.7% in Liberia, a difference of 0.3%.
Across all 6 years both countries report, Gambia has been ahead every year.
Gambia ranks 150th and Liberia ranks 151st of 185 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.5% | 14.8% | 2.7% | Gambia |
| 2010s | 21.7% | 18.2% | 3.5% | Gambia |
| 2020s | 22.2% | 22.0% | 0.1% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Gambia or Liberia?
- Gambia, at 22.0% against 21.7% in Liberia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Gambia and Liberia?
- 0.3%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Liberia?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Liberia rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Gambia ranks 150th and Liberia ranks 151st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.